![Christina Ackermann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christina Ackermann
Direktor/Vorstandsmitglied bei
SYNERGETICS USA INC
Vermögen: 148 218 $ am 31.05.2026
Profil
Christina Maria Ackermann is currently Secretary & Director at Synergetics USA, Inc., Co-Managing Director at Dr. Robert Winzer Pharma GmbH since 2017, and Independent Non-Executive Director at Oculis Holding AG since 2023.
Former positions include Chairman at Virometix AG (2022–2023), Independent Director at Graybug Vision, Inc. (2021–2023), Independent Non-Executive Director at Verona Pharma Ltd. (2023–2025), Associate General Counsel at DuPont Pharmaceuticals Co. (1996–2000), Senior Vice President & General Counsel at Alcon Laboratories, Inc. (2012–2016), General Counsel & Global Head-Legal at Sandoz International GmbH (2007–2012), Associate General Counsel at Bristol-Myers Squibb Pharma Co. (2001–2002), Head-Legal Technical Operations & Ophthalmics at Novartis Pharma AG (2002–2005), President, Executive VP & General Counsel at Bausch + Lomb Corp.
(2022–2023), and Head-Commercial Operations at Bausch Health Cos., Inc. (2020–2022).
Education includes undergraduate studies at York University and graduate degrees from Queen's University and King's College London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OCULIS HOLDING AG 0,01 % | 31.12.2025 | 6.528 ( 0,01 % ) | 148 218 $ | 31.05.2026 |
Aktive Positionen von Christina Ackermann
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNERGETICS USA INC | Direktor/Vorstandsmitglied | - |
| OCULIS HOLDING AG | Direktor/Vorstandsmitglied | 03.03.2023 |
Dr. Robert Winzer Pharma GmbH
 Dr. Robert Winzer Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | 27.02.2017 |
Ehemalige bekannte Positionen von Christina Ackermann
| Unternehmen | Position | Ende |
|---|---|---|
| VERONA PHARMA PLC | Direktor/Vorstandsmitglied | 07.10.2025 |
Virometix AG
 Virometix AG BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines and immunotherapeutic drugs for prevention, treatment of infectious & chronic human diseases | Vorsitzender | 01.05.2023 |
| BAUSCH + LOMB CORPORATION | Präsident | 24.04.2023 |
| CALCIMEDICA, INC. | Direktor/Vorstandsmitglied | 01.03.2023 |
| BAUSCH HEALTH COMPANIES INC. | General Counsel | 01.07.2020 |
Ausbildung von Christina Ackermann
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
57
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, which focuses on developing transformative medicines for the treatment of chronic diseases of retina and optic nerve | Health Technology |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Health Technology |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Health Technology |
York University
 York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synergetics USA, Inc.
 Synergetics USA, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and supplies precision surgical devices | Health Technology |
Verona Pharma Plc
 Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb Pharma Co. | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Dr. Robert Winzer Pharma GmbH
Dr. Robert Winzer Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bausch Health Cos., Inc.
 Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Virometix AG
Virometix AG BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines and immunotherapeutic drugs for prevention, treatment of infectious & chronic human diseases | Health Technology |
Bausch + Lomb Corp.
 Bausch + Lomb Corp. Medical SpecialtiesHealth Technology Manufactures and sells eye care products | Health Technology |
Oculis Holding AG
 Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
